Companion Study: Rationale

  • D. S. Cannom
Conference paper


The heart failure pandemic afflicts 5 million people in the United States, accounts for 900,000 hospitalizations and causes or contributes to 300,000 deaths per years [1–3]. Pharmacologic therapy reduces heart failure progression, morbidity and mortality but still leaves many patients with symptoms and shortened survival. Thus any new modality such as cardiac resynchroniza- tion therapy (with or without backup defibrillation) has important implications for patient clinical status and, perhaps, survival.


Heart Failure Cardiac Resynchronization Therapy Cardiac Resynchronization Therapy Device Annual Scientific Session Patient Clinical Status 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hunt SA, Baker DW, Chin MH et al (2001) ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. Circulation 104:2996–3007PubMedCrossRefGoogle Scholar
  2. 2.
    Cleland JGF, Khand A, Clark AL (2001) The heart failure epidemic: exactly how big is it? Eur J Heart Fail 22:623–626CrossRefGoogle Scholar
  3. 3.
    Kannel WB, Belanger AJ (1991) Epidemiology of heart failure. Am Heart J 121:951–957PubMedCrossRefGoogle Scholar
  4. 4.
    From Resynchronization Therapy for Heart Failure Expert Consensus Conference held at NASPE’s 23rd Annual Scientific Session (2002) held in San Diego, California.Google Scholar
  5. 5.
    St John Sutton MG, Plappert TJ, Abraham WT et al (2002) Cardiac resynchronization therapy results in improvement in echocardiographic parameters in heart failure patients: evidence from MIRACLE and MIRACLE ICD trials. J Cardiac Fail 8(4):abstract 034CrossRefGoogle Scholar
  6. 6.
    Bristow MR, Feldman AM, Saxon LA (2000) Heart failure management using implan-table devices for ventricular resynchronization: comparison of medical therapy, pacing, and defibrillation in chronic heart failure (COMPANION) trial. J Card Fail 6:276–285PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2004

Authors and Affiliations

  • D. S. Cannom
    • 1
  1. 1.Department of CardiologyGood Samaritan HospitalLos AngelesUSA

Personalised recommendations